What was Alaunos Therapeutics’s price range in the past 12 months?
Alaunos Therapeutics lowest stock price was $0.56 and its highest was $7.50 in the past 12 months.
What is Alaunos Therapeutics’s market cap?
Currently, no data Available
When is Alaunos Therapeutics’s upcoming earnings report date?
Alaunos Therapeutics’s upcoming earnings report date is Aug 08, 2024 which is in 22 days.
How were Alaunos Therapeutics’s earnings last quarter?
Alaunos Therapeutics released its earnings results on May 09, 2024. The company reported -$0.105 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.105.
Alaunos Therapeutics does not currently pay dividends.
What is Alaunos Therapeutics’s EPS estimate?
Alaunos Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Alaunos Therapeutics have?
Alaunos Therapeutics has 16,012,522 shares outstanding.
What happened to Alaunos Therapeutics’s price movement after its last earnings report?
Alaunos Therapeutics reported an EPS of -$0.105 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 0.758%.
Which hedge fund is a major shareholder of Alaunos Therapeutics?
Among the largest hedge funds holding Alaunos Therapeutics’s share is Discovery Capital Management, LLC. It holds Alaunos Therapeutics’s shares valued at N/A.
ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of a diverse portfolio of cancer therapies. It focuses on developing products in immuno-oncology that employ novel gene expression, control, and cell technologies for the treatment of cancer. The company was founded on September 9, 2003 and is headquartered in Boston, MA.